25 XP   0   0   10

Diaceutics PLC
Buy, Hold or Sell?

Let's analyse Diaceutics together

PenkeI guess you are interested in Diaceutics PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Diaceutics PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Diaceutics PLC

I send you an email if I find something interesting about Diaceutics PLC.

Quick analysis of Diaceutics (30 sec.)










What can you expect buying and holding a share of Diaceutics? (30 sec.)

How much money do you get?

How much money do you get?
p0.01
When do you have the money?
1 year
How often do you get paid?
57.1%

What is your share worth?

Current worth
p49.38
Expected worth in 1 year
p55.50
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
p7.00
Return On Investment
6.8%

For what price can you sell your share?

Current Price per Share
p103.00
Expected price per share
p102.25 - p107.00
How sure are you?
50%

1. Valuation of Diaceutics (5 min.)




Live pricePrice per Share (EOD)

p103.00

Intrinsic Value Per Share

p-39.78 - p34.52

Total Value Per Share

p9.61 - p83.90

2. Growth of Diaceutics (5 min.)




Is Diaceutics growing?

Current yearPrevious yearGrowGrow %
How rich?$52.9m$50.6m$2.3m4.4%

How much money is Diaceutics making?

Current yearPrevious yearGrowGrow %
Making money$902.1k$699k$203.1k22.5%
Net Profit Margin3.7%4.0%--

How much money comes from the company's main activities?

3. Financial Health of Diaceutics (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#84 / 145

Most Revenue
#85 / 145

Most Profit
#63 / 145

What can you expect buying and holding a share of Diaceutics? (5 min.)

Welcome investor! Diaceutics's management wants to use your money to grow the business. In return you get a share of Diaceutics.

What can you expect buying and holding a share of Diaceutics?

First you should know what it really means to hold a share of Diaceutics. And how you can make/lose money.

Speculation

The Price per Share of Diaceutics is p103.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Diaceutics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Diaceutics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p49.38. Based on the TTM, the Book Value Change Per Share is p1.53 per quarter. Based on the YOY, the Book Value Change Per Share is p0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.22 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Diaceutics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.010.0%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share0.020.0%0.020.0%0.000.0%0.120.1%0.090.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.0%0.020.0%0.000.0%0.120.1%0.090.1%
Usd Price Per Share0.94-0.94-1.27-1.03-0.74-
Price to Earnings Ratio89.78-89.78-154.44-178.21-127.30-
Price-to-Total Gains Ratio43.13-43.13-302.84-89.13-89.13-
Price to Book Ratio1.53-1.53-2.13-2.15-1.54-
Price-to-Total Gains Ratio43.13-43.13-302.84-89.13-89.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.283483
Number of shares779
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.12
Usd Total Gains Per Share0.020.12
Gains per Quarter (779 shares)16.9992.69
Gains per Year (779 shares)67.97370.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1959584366361
2171191269733732
3261781941310991103
4342372621814651474
5432973302218311845
6523563982721982216
7604154663125642587
8694755343629302958
9785346024032963329
10865946704536633700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%2.00.03.040.0%4.00.03.057.1%4.00.03.057.1%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Diaceutics

About Diaceutics PLC

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-21 06:32:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Diaceutics PLC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Diaceutics earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 3.7% means that 0.04 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Diaceutics PLC:

  • The MRQ is 3.7%. The company is making a profit. +1
  • The TTM is 3.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY4.0%-0.3%
TTM3.7%5Y3.8%-0.1%
5Y3.8%10Y6.3%-2.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%-6.7%+10.4%
TTM3.7%-6.7%+10.4%
YOY4.0%0.3%+3.7%
5Y3.8%-1.5%+5.3%
10Y6.3%-3.4%+9.7%
1.1.2. Return on Assets

Shows how efficient Diaceutics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • 1.5% Return on Assets means that Diaceutics generated 0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Diaceutics PLC:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY1.2%+0.3%
TTM1.5%5Y2.6%-1.1%
5Y2.6%10Y6.7%-4.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-1.3%+2.8%
TTM1.5%-1.3%+2.8%
YOY1.2%-0.9%+2.1%
5Y2.6%-0.5%+3.1%
10Y6.7%-0.9%+7.6%
1.1.3. Return on Equity

Shows how efficient Diaceutics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • 1.7% Return on Equity means Diaceutics generated 0.02 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Diaceutics PLC:

  • The MRQ is 1.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%0.0%
TTM1.7%YOY1.4%+0.3%
TTM1.7%5Y6.0%-4.2%
5Y6.0%10Y19.8%-13.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%-0.5%+2.2%
TTM1.7%-+1.7%
YOY1.4%0.3%+1.1%
5Y6.0%-1.4%+7.4%
10Y19.8%-2.3%+22.1%

1.2. Operating Efficiency of Diaceutics PLC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Diaceutics is operating .

  • Measures how much profit Diaceutics makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • An Operating Margin of 1.7% means the company generated 0.02  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Diaceutics PLC:

  • The MRQ is 1.7%. The company is operating less efficient.
  • The TTM is 1.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%0.0%
TTM1.7%YOY2.2%-0.5%
TTM1.7%5Y5.7%-4.0%
5Y5.7%10Y8.6%-2.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%-6.2%+7.9%
TTM1.7%0.5%+1.2%
YOY2.2%4.0%-1.8%
5Y5.7%3.7%+2.0%
10Y8.6%-1.3%+9.9%
1.2.2. Operating Ratio

Measures how efficient Diaceutics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are 0.98 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Diaceutics PLC:

  • The MRQ is 0.983. The company is less efficient in keeping operating costs low.
  • The TTM is 0.983. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.983TTM0.9830.000
TTM0.983YOY0.978+0.005
TTM0.9835Y0.947+0.036
5Y0.94710Y0.918+0.030
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9831.280-0.297
TTM0.9831.304-0.321
YOY0.9781.236-0.258
5Y0.9471.242-0.295
10Y0.9181.205-0.287

1.3. Liquidity of Diaceutics PLC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Diaceutics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 8.23 means the company has 8.23 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Diaceutics PLC:

  • The MRQ is 8.235. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.235. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.235TTM8.2350.000
TTM8.235YOY11.413-3.179
TTM8.2355Y8.210+0.024
5Y8.21010Y6.523+1.687
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2352.111+6.124
TTM8.2352.298+5.937
YOY11.4132.599+8.814
5Y8.2103.012+5.198
10Y6.5233.081+3.442
1.3.2. Quick Ratio

Measures if Diaceutics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • A Quick Ratio of 8.07 means the company can pay off 8.07 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Diaceutics PLC:

  • The MRQ is 8.067. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.067. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.067TTM8.0670.000
TTM8.067YOY11.250-3.183
TTM8.0675Y8.059+0.008
5Y8.05910Y6.443+1.616
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0671.204+6.863
TTM8.0671.319+6.748
YOY11.2501.602+9.648
5Y8.0591.943+6.116
10Y6.4432.203+4.240

1.4. Solvency of Diaceutics PLC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Diaceutics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Diaceutics to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.12 means that Diaceutics assets are financed with 11.9% credit (debt) and the remaining percentage (100% - 11.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Diaceutics PLC:

  • The MRQ is 0.119. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.119. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.119TTM0.1190.000
TTM0.119YOY0.097+0.022
TTM0.1195Y0.211-0.092
5Y0.21110Y0.346-0.135
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1190.429-0.310
TTM0.1190.407-0.288
YOY0.0970.394-0.297
5Y0.2110.450-0.239
10Y0.3460.450-0.104
1.4.2. Debt to Equity Ratio

Measures if Diaceutics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Diaceutics to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 13.5% means that company has 0.14 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Diaceutics PLC:

  • The MRQ is 0.135. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.135. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.1350.000
TTM0.135YOY0.107+0.028
TTM0.1355Y0.481-0.346
5Y0.48110Y0.961-0.480
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1350.606-0.471
TTM0.1350.571-0.436
YOY0.1070.631-0.524
5Y0.4810.658-0.177
10Y0.9610.735+0.226

2. Market Valuation of Diaceutics PLC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Diaceutics generates.

  • Above 15 is considered overpriced but always compare Diaceutics to the Diagnostics & Research industry mean.
  • A PE ratio of 89.78 means the investor is paying 89.78 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Diaceutics PLC:

  • The EOD is 122.475. Based on the earnings, the company is expensive. -2
  • The MRQ is 89.776. Based on the earnings, the company is expensive. -2
  • The TTM is 89.776. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD122.475MRQ89.776+32.700
MRQ89.776TTM89.7760.000
TTM89.776YOY154.440-64.665
TTM89.7765Y178.214-88.438
5Y178.21410Y127.296+50.918
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD122.475-0.235+122.710
MRQ89.776-0.395+90.171
TTM89.776-0.284+90.060
YOY154.4400.002+154.438
5Y178.2144.834+173.380
10Y127.2965.200+122.096
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Diaceutics PLC:

  • The EOD is 318.965. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 233.804. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 233.804. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD318.965MRQ233.804+85.160
MRQ233.804TTM233.8040.000
TTM233.804YOY-17.221+251.026
TTM233.8045Y34.713+199.091
5Y34.71310Y24.795+9.918
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD318.965-0.277+319.242
MRQ233.804-0.441+234.245
TTM233.804-1.389+235.193
YOY-17.221-2.030-15.191
5Y34.713-1.446+36.159
10Y24.795-1.971+26.766
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Diaceutics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.53 means the investor is paying 1.53 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Diaceutics PLC:

  • The EOD is 2.086. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.529. Based on the equity, the company is underpriced. +1
  • The TTM is 1.529. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.086MRQ1.529+0.557
MRQ1.529TTM1.5290.000
TTM1.529YOY2.131-0.603
TTM1.5295Y2.152-0.623
5Y2.15210Y1.537+0.615
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.0861.897+0.189
MRQ1.5292.222-0.693
TTM1.5292.168-0.639
YOY2.1313.041-0.910
5Y2.1523.477-1.325
10Y1.5374.125-2.588
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Diaceutics PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5291.5290%0.337+354%9.433-84%7.055-78%
Book Value Per Share--49.38349.3830%47.855+3%34.327+44%25.007+97%
Current Ratio--8.2358.2350%11.413-28%8.210+0%6.523+26%
Debt To Asset Ratio--0.1190.1190%0.097+23%0.211-44%0.346-66%
Debt To Equity Ratio--0.1350.1350%0.107+26%0.481-72%0.961-86%
Dividend Per Share--0.2220.2220%-+100%0.115+92%0.184+21%
Eps--0.8410.8410%0.660+27%0.606+39%0.671+25%
Free Cash Flow Per Share--0.3230.3230%-5.923+1934%-3.873+1299%-2.447+858%
Free Cash Flow To Equity Per Share--0.1700.1700%-6.241+3780%4.052-96%3.335-95%
Gross Profit Margin--4.5554.5550%3.895+17%2.445+86%2.032+124%
Intrinsic Value_10Y_max--34.516--------
Intrinsic Value_10Y_min---39.777--------
Intrinsic Value_1Y_max---2.298--------
Intrinsic Value_1Y_min---4.222--------
Intrinsic Value_3Y_max---2.516--------
Intrinsic Value_3Y_min---12.557--------
Intrinsic Value_5Y_max--2.554--------
Intrinsic Value_5Y_min---20.685--------
Market Cap8721967488.000+25%6499758835.5006499758835.5000%8664099810.000-25%7021166570.700-7%5015118979.071+30%
Net Profit Margin--0.0370.0370%0.040-8%0.038-2%0.063-41%
Operating Margin--0.0170.0170%0.022-24%0.057-70%0.086-80%
Operating Ratio--0.9830.9830%0.978+1%0.947+4%0.918+7%
Pb Ratio2.086+27%1.5291.5290%2.131-28%2.152-29%1.537-1%
Pe Ratio122.475+27%89.77689.7760%154.440-42%178.214-50%127.296-29%
Price Per Share103.000+27%75.50075.5000%102.000-26%82.600-9%59.000+28%
Price To Free Cash Flow Ratio318.965+27%233.804233.8040%-17.221+107%34.713+574%24.795+843%
Price To Total Gains Ratio58.843+27%43.13243.1320%302.841-86%89.133-52%89.133-52%
Quick Ratio--8.0678.0670%11.250-28%8.059+0%6.443+25%
Return On Assets--0.0150.0150%0.012+20%0.026-43%0.067-78%
Return On Equity--0.0170.0170%0.014+23%0.060-71%0.198-91%
Total Gains Per Share--1.7501.7500%0.337+420%9.548-82%7.238-76%
Usd Book Value--52976695.40052976695.4000%50652718.900+5%36426630.213+45%26533479.840+100%
Usd Book Value Change Per Share--0.0190.0190%0.004+354%0.118-84%0.088-78%
Usd Book Value Per Share--0.6150.6150%0.596+3%0.428+44%0.312+97%
Usd Dividend Per Share--0.0030.0030%-+100%0.001+92%0.002+21%
Usd Eps--0.0100.0100%0.008+27%0.008+39%0.008+25%
Usd Free Cash Flow--346415.800346415.8000%-6269129.100+1910%-4089584.562+1281%-2583574.911+846%
Usd Free Cash Flow Per Share--0.0040.0040%-0.074+1934%-0.048+1299%-0.030+858%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%-0.078+3780%0.050-96%0.042-95%
Usd Market Cap108684436.868+25%80993494.84980993494.8490%107963347.732-25%87490756.637-7%62493397.598+30%
Usd Price Per Share1.283+27%0.9410.9410%1.271-26%1.029-9%0.735+28%
Usd Profit--902176.400902176.4000%699062.100+29%642536.013+40%710013.539+27%
Usd Revenue--24303934.40024303934.4000%17374372.300+40%17435007.775+39%14582504.298+67%
Usd Total Gains Per Share--0.0220.0220%0.004+420%0.119-82%0.090-76%
 EOD+4 -4MRQTTM+0 -0YOY+24 -125Y+20 -1610Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Diaceutics PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15122.475
Price to Book Ratio (EOD)Between0-12.086
Net Profit Margin (MRQ)Greater than00.037
Operating Margin (MRQ)Greater than00.017
Quick Ratio (MRQ)Greater than18.067
Current Ratio (MRQ)Greater than18.235
Debt to Asset Ratio (MRQ)Less than10.119
Debt to Equity Ratio (MRQ)Less than10.135
Return on Equity (MRQ)Greater than0.150.017
Return on Assets (MRQ)Greater than0.050.015
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Diaceutics PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.459
Ma 20Greater thanMa 50104.000
Ma 50Greater thanMa 100101.280
Ma 100Greater thanMa 20096.840
OpenGreater thanClose103.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Other Income Expense Net -52,866-125,166-178,033146,133-31,90029,900-2,00016,70014,700



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets48,256
Total Liabilities5,742
Total Stockholder Equity42,514
 As reported
Total Liabilities 5,742
Total Stockholder Equity+ 42,514
Total Assets = 48,256

Assets

Total Assets48,256
Total Current Assets30,896
Long-term Assets17,360
Total Current Assets
Cash And Cash Equivalents 19,841
Net Receivables 10,427
Other Current Assets 628
Total Current Assets  (as reported)30,896
Total Current Assets  (calculated)30,896
+/-0
Long-term Assets
Property Plant Equipment 2,092
Intangible Assets 15,222
Other Assets 224
Long-term Assets  (as reported)17,360
Long-term Assets  (calculated)17,538
+/- 178

Liabilities & Shareholders' Equity

Total Current Liabilities3,752
Long-term Liabilities1,990
Total Stockholder Equity42,514
Total Current Liabilities
Short-term Debt 124
Accounts payable 759
Other Current Liabilities 2,458
Total Current Liabilities  (as reported)3,752
Total Current Liabilities  (calculated)3,341
+/- 411
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,205
Other Liabilities 785
Long-term Liabilities  (as reported)1,990
Long-term Liabilities  (calculated)1,990
+/-0
Total Stockholder Equity
Common Stock169
Retained Earnings 5,344
Accumulated Other Comprehensive Income 138
Other Stockholders Equity 36,863
Total Stockholder Equity (as reported)42,514
Total Stockholder Equity (calculated)42,514
+/-0
Other
Capital Stock169
Cash and Short Term Investments 19,841
Common Stock Shares Outstanding 86,090
Current Deferred Revenue411
Liabilities and Stockholders Equity 48,256
Net Debt -18,512
Net Invested Capital 42,514
Net Tangible Assets 27,470
Net Working Capital 27,144
Property Plant and Equipment Gross 2,092
Short Long Term Debt Total 1,329



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
1,341
3,441
5,492
7,810
22,371
43,519
45,013
48,256
48,25645,01343,51922,3717,8105,4923,4411,341
   > Total Current Assets 
1,324
3,231
4,828
6,463
18,421
33,619
30,062
30,896
30,89630,06233,61918,4216,4634,8283,2311,324
       Cash And Cash Equivalents 
125
1,286
3,069
2,074
11,720
25,255
19,675
19,841
19,84119,67525,25511,7202,0743,0691,286125
       Net Receivables 
250
2,271
1,686
4,082
6,371
7,777
9,957
10,427
10,4279,9577,7776,3714,0821,6862,271250
       Other Current Assets 
949
1,945
1,759
307
330
587
430
628
6284305873303071,7591,945949
   > Long-term Assets 
18
209
663
472
3,950
9,900
14,951
17,360
17,36014,9519,9003,95047266320918
       Property Plant Equipment 
3
19
49
74
134
238
2,129
2,092
2,0922,1292381347449193
       Long Term Investments 
0
0
0
0
0
0
0
0
00000000
       Intangible Assets 
15
18
487
398
3,761
9,361
12,821
15,222
15,22212,8219,3613,7613984871815
       Other Assets 
0
172
333
875
0
0
0
224
2240008753331720
> Total Liabilities 
1,175
2,428
3,614
5,181
2,239
3,281
4,364
5,742
5,7424,3643,2812,2395,1813,6142,4281,175
   > Total Current Liabilities 
927
1,422
2,064
3,935
2,239
2,915
2,634
3,752
3,7522,6342,9152,2393,9352,0641,422927
       Short-term Debt 
74
436
537
2,682
108
118
276
124
1242761181082,68253743674
       Short Long Term Debt 
74
436
537
2,682
108
118
130
0
01301181082,68253743674
       Accounts payable 
120
81
181
224
291
466
513
759
75951346629122418181120
       Other Current Liabilities 
807
867
1,006
809
1,453
2,028
1,637
2,458
2,4581,6372,0281,4538091,006867807
   > Long-term Liabilities 
247
1,006
1,550
1,065
2,239
366
1,730
1,990
1,9901,7303662,2391,0651,5501,006247
       Long term Debt 
247
1,006
1,550
1,065
0
0
0
0
00001,0651,5501,006247
       Capital Lease Obligations 
0
0
0
0
0
0
1,431
1,329
1,3291,431000000
       Other Liabilities 
0
0
0
181
0
366
445
785
7854453660181000
       Deferred Long Term Liability 
0
0
206
812
2,383
422
216
178
1782164222,38381220600
> Total Stockholder Equity
167
1,012
1,878
2,629
20,132
40,238
40,649
42,514
42,51440,64940,23820,1322,6291,8781,012167
   Common Stock
109
0
0
0
139
168
168
169
169168168139000109
   Retained Earnings 
-42
706
1,504
2,242
2,638
3,191
4,084
5,344
5,3444,0843,1912,6382,2421,504706-42
   Capital Surplus 
0
100
100
100
17,335
36,864
0
0
0036,86417,3351001001000
   Treasury Stock00000000
   Other Stockholders Equity 
100
342
424
100
17,335
36,864
36,699
36,863
36,86336,69936,86417,335100424342100



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue19,504
Cost of Revenue-5,467
Gross Profit14,03714,037
 
Operating Income (+$)
Gross Profit14,037
Operating Expense-13,706
Operating Income331331
 
Operating Expense (+$)
Research Development-
Selling General Administrative16,280
Selling And Marketing Expenses-2,574
Operating Expense13,70613,706
 
Net Interest Income (+$)
Interest Income111
Interest Expense-122
Other Finance Cost-0
Net Interest Income-11
 
Pretax Income (+$)
Operating Income331
Net Interest Income-11
Other Non-Operating Income Expenses-
Income Before Tax (EBT)478184
EBIT - interestExpense = 209
478
846
Interest Expense122
Earnings Before Interest and Taxes (EBIT)331600
Earnings Before Interest and Taxes (EBITDA)3,339
 
After tax Income (+$)
Income Before Tax478
Tax Provision--160
Net Income From Continuing Ops724638
Net Income724
Net Income Applicable To Common Shares724
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses19,173
Total Other Income/Expenses Net14711
 

Technical Analysis of Diaceutics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Diaceutics. The general trend of Diaceutics is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Diaceutics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Diaceutics PLC.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 107.00 < 107.00 < 107.00.

The bearish price targets are: 103.00 > 103.00 > 102.25.

Tweet this
Diaceutics PLC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Diaceutics PLC. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Diaceutics PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Diaceutics PLC. The current macd is 0.41159622.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Diaceutics price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Diaceutics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Diaceutics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Diaceutics PLC Daily Moving Average Convergence/Divergence (MACD) ChartDiaceutics PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Diaceutics PLC. The current adx is 12.33.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Diaceutics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Diaceutics PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Diaceutics PLC. The current sar is 106.30.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Diaceutics PLC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Diaceutics PLC. The current rsi is 50.46. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Diaceutics PLC Daily Relative Strength Index (RSI) ChartDiaceutics PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Diaceutics PLC. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Diaceutics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Diaceutics PLC Daily Stochastic Oscillator ChartDiaceutics PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Diaceutics PLC. The current cci is -138.58150092.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Diaceutics PLC Daily Commodity Channel Index (CCI) ChartDiaceutics PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Diaceutics PLC. The current cmo is -11.30759059.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Diaceutics PLC Daily Chande Momentum Oscillator (CMO) ChartDiaceutics PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Diaceutics PLC. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Diaceutics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Diaceutics PLC Daily Williams %R ChartDiaceutics PLC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Diaceutics PLC.

Diaceutics PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Diaceutics PLC. The current atr is 1.69340248.

Diaceutics PLC Daily Average True Range (ATR) ChartDiaceutics PLC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Diaceutics PLC. The current obv is -2,272,098.

Diaceutics PLC Daily On-Balance Volume (OBV) ChartDiaceutics PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Diaceutics PLC. The current mfi is 5.95561606.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Diaceutics PLC Daily Money Flow Index (MFI) ChartDiaceutics PLC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Diaceutics PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Diaceutics PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Diaceutics PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.459
Ma 20Greater thanMa 50104.000
Ma 50Greater thanMa 100101.280
Ma 100Greater thanMa 20096.840
OpenGreater thanClose103.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Diaceutics with someone you think should read this too:
  • Are you bullish or bearish on Diaceutics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Diaceutics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Diaceutics PLC

I send you an email if I find something interesting about Diaceutics PLC.


Comments

How you think about this?

Leave a comment

Stay informed about Diaceutics PLC.

Receive notifications about Diaceutics PLC in your mailbox!